Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study

dc.contributor.authorPasqual, Elisa
dc.contributor.authorTurner, Michelle C.
dc.contributor.authorGracia Lavedan, Esther
dc.contributor.authorCasabonne, Delphine
dc.contributor.authorBenavente, Yolanda
dc.contributor.authorThierry-Chef, Isabelle
dc.contributor.authorMaynadié, Marc
dc.contributor.authorCocco, Pierluigi
dc.contributor.authorStaines, Anthony
dc.contributor.authorForetova, Lenka
dc.contributor.authorNieters, Alexandra
dc.contributor.authorBoffetta, Paolo
dc.contributor.authorBrennan, Paul
dc.contributor.authorCardis, Elisabeth
dc.contributor.authorSanjosé Llongueras, Silvia de
dc.date.accessioned2020-11-04T11:18:13Z
dc.date.available2020-11-04T11:18:13Z
dc.date.issued2020-07-10
dc.date.updated2020-11-03T17:08:48Z
dc.description.abstractMedical diagnostic X-rays are an important source of ionizing radiation (IR) exposure in the general population; however, it is unclear if the resulting low patient doses increase lymphoma risk. We examined the association between lifetime medical diagnostic X-ray dose and lymphoma risk, taking into account potential confounding factors, including medical history. The international Epilymph study (conducted in the Czech-Republic, France, Germany, Ireland, Italy, and Spain) collected self-reported information on common diagnostic X-ray procedures from 2,362 lymphoma cases and 2,465 frequency-matched (age, sex, country) controls. Individual lifetime cumulative bone marrow (BM) dose was estimated using time period-based dose estimates for different procedures and body parts. The association between categories of BM dose and lymphoma risk was examined using unconditional logistic regression models adjusting for matching factors, socioeconomic variables, and the presence of underlying medical conditions (atopic, autoimmune, infectious diseases, osteoarthritis, having had a sick childhood, and family history of lymphoma) as potential confounders of the association. Cumulative BM dose was low (median 2.25 mGy) and was not positively associated with lymphoma risk. Odds ratios (ORs) were consistently less than 1.0 in all dose categories compared to the reference category (less than 1 mGy). Results were similar after adjustment for potential confounding factors, when using different exposure scenarios, and in analyses by lymphoma subtype and by type of control (hospital-, population-based). Overall no increased risk of lymphoma was observed. The reduced ORs may be related to unmeasured confounding or other sources of systematic bias.We found little evidence that chronic medical conditions confound lymphoma risk and medical radiation associations.
dc.format.extent19 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid32649712
dc.identifier.urihttps://hdl.handle.net/2445/171744
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0235658
dc.relation.ispartofPLoS One, 2020, vol. 15, num. 7, p. e0235658
dc.relation.urihttps://doi.org/10.1371/journal.pone.0235658
dc.rightscc by (c) Pasqual et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationCàncer
dc.subject.classificationLimfomes
dc.subject.classificationFactors de risc en les malalties
dc.subject.otherCancer
dc.subject.otherLymphomas
dc.subject.otherRisk factors in diseases
dc.titleAssociation of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
PasqualE.pdf
Mida:
592.16 KB
Format:
Adobe Portable Document Format